Molecular mechanisms by which selenoproteins affect cancer risk and progression

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 11, 2009, Pages 1546-1554

  Zhuo, Pin ^a   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti oxidant; Cancer; Loss of heterozygosity; Polymorphism; Selenoprotein

Indexed keywords

BRCA1 PROTEIN; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; S6 KINASE; SELENIUM; SELENOPROTEIN; SELENOPROTEIN P; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL STRESS; COLON CANCER; DIET SUPPLEMENTATION; DOSE RESPONSE; GENE SILENCING; GENETIC RISK; HETEROZYGOSITY; HUMAN; LIVER CANCER; LUNG CANCER; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HUMANS; MICE; NEOPLASMS; RISK; SELENOPROTEIN P; SELENOPROTEINS;

EID: 72649104264     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.03.004     Document Type: Review

References (121)

1. Kim H., Kang H.J., You K.T., et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6 (2006) 3466-3476
2. Li T., Yang W., Li M., et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol. Nutr. Food Res. 52 (2008) 1289-1299
3. In: El-Bayoumy K. (Ed). The Role of Selenium in Cancer Prevention (1991), J.B. Lippincott Co., Philadelphia
4. Etminan M., FitzGerald J.M., Gleave M., and Chambers K. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control 16 (2005) 1125-1131
5. Brinkman M., Reulen R.C., Kellen E., Buntinx F., and Zeegers M.P. Are men with low selenium levels at increased risk of prostate cancer?. Eur. J. Cancer 42 (2006) 2463-2471
6. Jacobs E.T., Jiang R., Alberts D.S., et al. Selenium and colorectal adenoma: results of a pooled analysis. J. Natl. Cancer Inst. 96 (2004) 1669-1675
7. Peters U., Chatterjee N., Church T.R., et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 315-320
8. Kryukov G.V., Castellano S., Novoselov S.V., et al. Characterization of mammalian selenoproteomes. Science 300 (2003) 1439-1443
9. Nadiminty N., and Gao A.C. Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol. Nutr. Food Res. 52 (2008) 1247-1260
10. Hatfield D.L., and Gladyshev V.N. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22 (2002) 3565-3576
11. Warner G.J., Berry M.J., Moustafa M.E., et al. Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine. J. Biol. Chem. 275 (2000) 28110-28119
12. Moustafa M.E., Carlson B.A., El-Saadani M.A., et al. Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA. Mol. Cell. Biol. 21 (2001) 3840-3852
13. Irons R., Carlson B.A., Hatfield D.L., and Davis C.D. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J. Nutr. 136 (2006) 1311-1317
14. Diwadkar-Navsariwala V., Prins G.S., Swanson S.M., et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 8179-8184
15. Hornberger T.A., McLoughlin T.J., Leszczynski J.K., et al. Selenoprotein-deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J. Nutr. 133 (2003) 3091-3097
16. Kumaraswamy E., Carlson B.A., Morgan F., et al. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 23 (2003) 1477-1488
17. Kowalska E., Narod S.A., Huzarski T., et al. Increased rates of chromosomal breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1302-1306
18. Baliga M.S., Wang H., Zhuo P., Schwartz J.L., and Diamond A.M. Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol. Trace Elem. Res. 115 (2007) 227-242
19. Mörk H., al-Taie O.H., Bähr K., et al. Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr. Cancer 37 (2000) 108-116
20. Murawaki Y., Tsuchiya H., Kanbe T., et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259 (2008) 218-230
21. Gresner P., Gromadzinska J., Jablonska E., Kaczmarski J., and Wasowicz W. Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer (2008) 2
22. Calvo A., Xiao N., Kang J., et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 62 (2002) 5325-5335
23. Persson-Moschos M.E., Stavenow L., Akesson B., and Lindgärde F. Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men. Nutr. Cancer 36 (2000) 19-26
24. Méplan C., Crosley L.K., Nicol F., et al. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 21 (2007) 3063-3074
25. Al-Taie O.H., Uceyler N., Eubner U., et al. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr. Cancer 48 (2004) 6-14
26. Foster C.B., Aswath K., Chanock S.J., McKay H.F., and Peters U. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet. 7 (2006) 56
27. Al-Taie O.H., Seufert J., Mörk H., et al. A complex DNA-repeat structure within the Selenoprotein P promoter contains a functionally relevant polymorphism and is genetically unstable under conditions of mismatch repair deficiency. Eur. J. Hum. Genet. 10 (2002) 499-504
28. Peters U., Chatterjee N., Hayes R.B., et al. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 1144-1154
29. Cooper M.L., Adami H.O., Grönberg H., Wiklund F., Green F.R., and Rayman M.P. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res. 68 (2008) 10171-10177
30. Sutton A., Imbert A., Igoudjil A., et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet. Genomics 15 (2005) 311-319
31. Li H., Kantoff P.W., Giovannucci E., et al. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res. 65 (2005) 2498-2504
32. Cox D.G., Tamimi R.M., and Hunter D.J. Gene × Gene interaction between MnSOD and GPX-1 and breast cancer risk: a nested case-control study. BMC Cancer 6 (2006) 217
33. Burk R.F., Hill K.E., and Motley A.K. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J. Nutr. 133 (2003) 1517S-1520S
34. Hill K.E., Zhou J., McMahan W.J., et al. Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278 (2003) 13640-13646
35. Schomburg L., Schweizer U., Holtmann B., et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370 (2003) 397-402
36. Burk R.F., and Hill K.E. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu. Rev. Nutr. 25 (2005) 215-235
37. Steinbrenner H., Bilgic E., Alili L., Sies H., and Brenneisen P. Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radic. Res. 40 (2006) 936-943
38. Steinbrenner H., Alili L., Bilgic E., Sies H., and Brenneisen P. Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radic. Biol. Med. 40 (2006) 1513-1523
39. Schweizer U., Streckfuss F., Pelt P., et al. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386 (2005) 221-226
40. Arteel G.E., Mostert V., Oubrahim H., Briviba K., Abel J., and Sies H. Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration. Biol. Chem. 379 (1998) 1201-1205
41. Saito Y., Hayashi T., Tanaka A., et al. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p. J. Biol. Chem. 274 (1999) 2866-2871
42. Asayama K., Yokota S., Dobashi K., Hayashibe H., Kawaoi A., and Nakazawa S. Purification and immunoelectron microscopic localization of cellular glutathione peroxidase in rat hepatocytes: quantitative analysis by postembedding method. Histochemistry 102 (1994) 213-219
43. Esworthy R.S., Ho Y.S., and Chu F.F. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch. Biochem. Biophys. 340 (1997) 59-63
44. Hu Y.J., and Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 63 (2003) 3347-3351
45. Hu Y.J., Dolan M.E., Bae R., et al. Allelic loss at the GPx-1 locus in cancer of the head and neck. Biol. Trace Elem. Res. 101 (2004) 97-106
46. Hu Y., Benya R.V., Carroll R.E., and Diamond A.M. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J. Nutr. 135 (2005) 3021S-3024S
47. Ravn-Haren G., Olsen A., Tjønneland A., et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27 (2006) 820-825
48. Ratnasinghe D., Tangrea J.A., Andersen M.R., et al. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res. 60 (2000) 6381-6383
49. Ichimura Y., Habuchi T., Tsuchiya N., et al. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J. Urol. 172 (2004) 728-732
50. Lightfoot T.J., Skibola C.F., Smith A.G., et al. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 91 (2006) 1222-1227
51. Sutton A., Nahon P., Pessayre D., et al. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res. 66 (2006) 2844-2852
52. Lee C.H., Lee K.Y., Choe K.H., et al. Effects of oxidative DNA damage and genetic polymorphism of the glutathione peroxidase 1 (GPX1) and 8-oxoguanine glycosylase 1 (hOGG1) on lung cancer. J. Prev. Med. Public Health 39 (2006) 130-134
53. Vogel U., Olsen A., Wallin H., Overvad K., Tjønneland A., and Nexø B.A. No association between GPX Pro198Leu and risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1412-1413
54. Cox D.G., Hankinson S.E., Kraft P., and Hunter D.J. No association between GPX1 Pro198Leu and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1821-1822
55. Ahn J., Gammon M.D., Santella R.M., et al. No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2459-2461
56. Hansen R., Saebo M., Saebø M., et al. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett. 229 (2005) 85-91
57. Arsova-Sarafinovska Z., Matevska N., Eken A., et al. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int. Urol. Nephrol. 41 (2009) 63-70
58. Raaschou-Nielsen O., Sørensen M., Hansen R.D., et al. GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. Cancer Lett. 247 (2007) 293-300
59. Yang P., Bamlet W.R., Ebbert J.O., Taylor W.R., and de Andrade M. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 25 (2004) 1935-1944
60. Moscow J.A., Schmidt L., Ingram D.T., Gnarra J., Johnson B., and Cowan K.H. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 15 (1994) 2769-2773
61. Knight J.A., Onay U.V., Wells S., et al. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 146-149
62. Jefferies S., Kote-Jarai Z., Goldgar D., et al. Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. Oral Oncol. 41 (2005) 455-461
63. Kote-Jarai Z., Durocher F., Edwards S.M., et al. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis. 5 (2002) 189-192
64. Hardie L.J., Briggs J.A., Davidson L.A., et al. The effect of hOGG1 and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis 21 (2000) 167-172
65. Diamond A.M., Dale P., Murray J.L., and Grdina D.J. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat. Res. 356 (1996) 147-154
66. Baliga M.S., Diwadkar-Navsariwala V., Koh T., Fayad R., Fantuzzi G., and Diamond A.M. Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol. Nutr. Food Res. 52 (2008) 1300-1304
67. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
68. Nasr M.A., Fedele M.J., Esser K., and Diamond A.M. GPx-1 modulates Akt and P70(S6K) phosphorylation and Gadd45 levels in MCF-7 cells. Free Radic. Biol. Med. 37 (2004) 187-195
69. Maeda T., Hanna A.N., Sim A.B., Chua P.P., Chong M.T., and Tron V.A. GADD45 regulates G2/M arrest, DNA repair, and cell death in keratinocytes following ultraviolet exposure. J. Invest. Dermatol. 119 (2002) 22-26
70. Hollander M.C., and Fornace Jr. A.J. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21 (2002) 6228-6233
71. Hollander M.C., Sheikh M.S., Bulavin D.V., et al. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23 (1999) 176-184
72. Tran H., Brunet A., Grenier J.M., et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296 (2002) 530-534
73. Zhan Q. Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat. Res. 569 (2005) 133-143
74. Fischer J.L., Lancia J.K., Mathur A., and Smith M.L. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res. 26 (2006) 899-904
75. Takahashi K., Avissar N., Whitin J., and Cohen H. Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch. Biochem. Biophys. 256 (1987) 677-686
76. Avissar N., Ornt D.B., Yagil Y., et al. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol. 266 (1994) C367-375
77. Mörk H., Lex B., Scheurlen M., et al. Expression pattern of gastrointestinal selenoproteins-targets for selenium supplementation. Nutr. Cancer 32 (1998) 64-70
78. Tham D.M., Whitin J.C., Kim K.K., Zhu S.X., and Cohen H.J. Expression of extracellular glutathione peroxidase in human and mouse gastrointestinal tract. Am. J. Physiol. 275 (1998) G1463-1471
79. Lodygin D., Epanchintsev A., Menssen A., Diebold J., and Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 65 (2005) 4218-4227
80. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
81. Yu Y.P., Yu G., Tseng G., et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res. 67 (2007) 8043-8050
82. Lee O.J., Schneider-Stock R., McChesney P.A., et al. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 7 (2005) 854-861
83. Grond-Ginsbach C., Lichy C., Padovani A., and Pezzini A. GPx-3 gene promoter variation and the risk of arterial ischemic stroke. Stroke 38 (2007) e23 author reply e24
84. Voetsch B., Jin R.C., Bierl C., et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38 (2007) 41-49
85. Voetsch B., Jin R.C., Bierl C., et al. Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis. Stroke 39 (2008) 303-307
86. Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 27 (1999) 951-965
87. Ursini F., Heim S., Kiess M., et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 285 (1999) 1393-1396
88. Thomas J.P., Maiorino M., Ursini F., and Girotti A.W. Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J. Biol. Chem. 265 (1990) 454-461
89. Imai H., and Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic. Biol. Med. 34 (2003) 145-169
90. Ran Q., Liang H., Gu M., et al. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 279 (2004) 55137-55146
91. L. Lu, B.C. Oveson, Y.J. Jo, et al., Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage, Antioxid. Redox Signal (in press) [Electronic publication ahead of print].
92. Liang H., Van Remmen H., Frohlich V., Lechleiter J., Richardson A., and Ran Q. Gpx4 protects mitochondrial ATP generation against oxidative damage. Biochem. Biophys. Res. Commun. 356 (2007) 893-898
93. Dabkowski E.R., Williamson C.L., and Hollander J.M. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radic. Biol. Med. 45 (2008) 855-865
94. Yant L.J., Ran Q., Rao L., et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34 (2003) 496-502
95. Liu J., Du J., Zhang Y., et al. Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum. Gene Ther. 17 (2006) 105-116
96. Heirman I., Ginneberge D., Brigelius-Flohé R., et al. Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic. Biol. Med. 40 (2006) 285-294
97. Cejas P., García-Cabezas M.A., Casado E., et al. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma. Free Radic. Res. 41 (2007) 681-687
98. Villette S., Kyle J.A., Brown K.M., et al. A novel single nucleotide polymorphism in the 3′ untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis. 29 (2002) 174-178
99. Méplan C., Crosley L.K., Nicol F., et al. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am. J. Clin. Nutr. 87 (2008) 1019-1027
100. Bermano G., Pagmantidis V., Holloway N., et al. Evidence that a polymorphism within the 3′ UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr. 2 (2007) 225-232
101. Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol. Chem. 387 (2006) 1329-1335
102. Garry M.R., Kavanagh T.J., Faustman E.M., et al. Sensitivity of mouse lung fibroblasts heterozygous for GPx4 to oxidative stress. Free Radic. Biol. Med. 44 (2008) 1075-1087
103. Ran Q., Liang H., Ikeno Y., et al. Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis. J. Gerontol. A. Biol. Sci. Med. Sci. 62 (2007) 932-942
104. Gladyshev V.N., Jeang K., Wootton J.C., and Hatfield D.L. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J. Biol. Chem. 273 (1998) 8910-8915
105. Labunskyy V.M., Hatfield D.L., and Gladyshev V.N. The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life 59 (2007) 1-5
106. Labunskyy V.M., Ferguson A.D., Fomenko D.E., Chelliah Y., Hatfield D.L., and Gladyshev V.N. A novel cysteine-rich domain of Sep15 mediates the interaction with UDP-glucose:glycoprotein glucosyltransferase. J. Biol. Chem. 280 (2005) 37839-37845
107. Hu Y.J., Korotkov K.V., Mehta R., et al. Distribution and functional consequences of nucleotide polymorphisms in the 3′-untranslated region of the human Sep15 gene. Cancer Res. 61 (2001) 2307-2310
108. Nasr M.A., Hu Y.J., and Diamond A.M. Allelic loss at the Sep15 locus in breast cancer. Cancer Therapy 1 (2003) 293-298
109. Apostolou S., Klein J.O., Mitsuuchi Y., et al. Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 23 (2004) 5032-5040
110. Jablonska E., Gromadzinska J., Sobala W., Reszka E., and Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur. J. Nutr. 47 (2008) 47-54
111. Kumaraswamy E., Malykh A., Korotkov K.V., et al. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiolgy. J. Biol. Chem. 275 (2000) 35540-35547
112. Chu F.F., Esworthy R.S., Chu P.G., et al. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res. 64 (2004) 962-968
113. Lee D.H., Esworthy R.S., Chu C., Pfeifer G.P., and Chu F.F. Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res. 66 (2006) 9845-9851
114. Walshe J., Serewko-Auret M.M., Teakle N., et al. Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 67 (2007) 4751-4758
115. Chu F.F., Esworthy R.S., and Doroshow J.H. Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic. Biol. Med. 36 (2004) 1481-1495
116. Arnér E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
117. Arnér E.S., and Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 16 (2006) 420-426
118. Yoo M.H., Xu X.M., Carlson B.A., Gladyshev V.N., and Hatfield D.L. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J. Biol. Chem. 281 (2006) 13005-13008
119. Yoo M.H., Xu X.M., Carlson B.A., Patterson A.D., Gladyshev V.N., and Hatfield D.L. Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication. PLoS ONE 2 (2007) e1112
120. Lippman S.M., Klein E.A., Goodman P.J., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301 (2009) 39-51
121. Zhao H., Liang D., Grossman H.B., and Wu X. Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology 66 (2005) 769-774